Communication and transparency are required for efficient clinical trials, but how can you do this when you’re working with multiple external partners all using different systems with inconsistent reporting conventions?
Analyze Cloud Service provides intelligence, presenting timely status updates across your studies and insights to streamline operational processes. Through visually rich analytics and dashboards, we help transition your team from a process that is reactive to one that is more proactive.
Oracle Health Sciences empowers our visibility into the traditionally cumbersome process of activating investigative sites for clinical trials. We can ‘at-a-glance’ track milestones and associated activities on the critical path and view the end-to-end deliverables, allowing us to navigate sites successfully through the start-up phase to the point where patients can be enrolled. Additionally, capturing robust clinical and operational data allows us to enhance our predictability model for forecasting.
Learn the importance of this regulation and its impact on large multi-country studies.
Learn how decentralized clinical trials have forced the industry to rethink their approach to study startup and associated regulations.
Learn how the traditional steps needed to start clinical trials need to be expanded upon, collapsed, and fit for purpose.
The way clinical trials are conducted in the European Union will undergo a major change when this regulation comes into effect in January 2022, which is binding across all member states.
As CROs fight to maintain market share and ensure long-term survival, those capable of critical thinking and proactive planning may be well-positioned to reap the rewards.
Learn about forthcoming guidance which renews the focus on efficiencies in conducting clinical trials and provide tools to do so - significantly impacting oversight.
Learn how Pfizer successfully brought a highly effective and safe COVID-19 vaccine to market in under a year, and how these same breakthroughs could be applied to other studies.
Learn how trusted collaboration is key to keeping sponsor-CRO partnerships aligned on shared goals.
Learn how the focus on efficiency in ICH E6 (R3) will fundamentally change clinical trials.
Learn how machine learning can help identify and rectify systemic inefficiencies, allowing life science organizations to learn and adapt.
Learn how the collaboration between Cognizant and Oracle eliminates redundancy for sites and deliver better outcomes from sponsors/CROs.
Will the industry embrace this change or revert back to its old ways post-COVID-19?
Learn how vendor oversight can be implemented end-to-end, ensuring compliance with ICH regulation guidelines.
Learn how to gain critical operational insights by using AI/machine learning to transition from subjective decision making.
Learn how digital transformation roadmaps were accelerated to embrace innovative approaches to overcome adversary.
Clinical trials are constantly evolving, with advancements in technology, industry initiatives, regulatory, and process changes. Gain perspective and learn more about these changes in the resources below.